Polynucleotides encoding anti-factor XI monoclonal antibodies and methods of use thereof
The present invention relates to compositions and methods for inhibiting thrombosis without compromising hemostasis. Compositions include anti-factor XI monoclonal antibodies (aXIMabs) capable of binding to an epitope on the heavy chain of human FXI, particularly the A3 domain of the heavy chain of human FXI. Compositions also include epitope-binding fragments, variants, and derivatives of the monoclonal antibodies, cell lines producing these antibody compositions, and isolated nucleic acid molecules encoding the amino acid sequences of the antibodies. The invention further includes pharmaceutical compositions comprising the anti-factor XI monoclonal antibodies of the invention, or epitope-binding fragments, variants, or derivatives thereof, in a pharmaceutically acceptable carrier. Methods of the invention comprise administering the compositions described above to a subject in need thereof for the purpose of inhibiting thrombosis, reducing a required dose of an antithrombotic agent in the treatment of thrombosis, treating metastatic cancer, or treating an acute inflammatory reaction.
1. An isolated polynucleotide encoding an anti-Factor XI (FXI) antibody or biologically active fragment thereof, wherein the antibody or biologically active fragment thereof comprises:
(a) an immunoglobulin heavy chain variable domain comprising three complementarity-determining regions (CDRs), wherein the three CDRs comprise the amino acid sequence of SEQ ID NO: 10, SEQ ID NO: 11 and SEQ ID NO: 12; and
(b) an immunoglobulin light chain variable domain comprising three CDRs, wherein the three CDRs comprise the amino acid sequence of SEQ ID NO: 13, SEQ ID NO: 14 and SEQ ID NO: 15.
2. The isolated polynucleotide of claim 1 , wherein the antibody or biologically active fragment thereof comprises an immunoglobulin heavy chain variable domain comprising an amino acid sequence selected from the group consisting of:
a) the amino acid sequence set forth in SEQ ID NO: 3 or 7; and
b) the amino acid sequence having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 3 or 7.
3. The isolated polynucleotide of claim 1 , wherein said antibody or biologically active fragment thereof comprises an immunoglobulin light chain variable domain comprising an amino acid sequence selected from the group consisting of:
a) the amino acid sequence set forth in SEQ ID NO: 5 or 9; and
b) the amino acid sequence having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO: 5 or 9.
4. The isolated polynucleotide of claim 1 , wherein the biologically active fragment is an Fab fragment, Fab' fragment, an F(ab′) 2 fragment, a single chain Fv (scFv), or a disulfide-linked Fv (dsFv).
5. The isolated polynucleotide of claim 1 , wherein the antibody is an IgG.
6. A vector comprising the polynucleotide of claim 1 .
7. An isolated host cell comprising the vector of claim 6 .
8. An isolated polynucleotide encoding an anti-Factor XI (FXI) antibody or biologically active fragment thereof, wherein the antibody or biologically active fragment thereof comprises:
(a) a variable heavy (VH) domain comprising the amino acid sequence of SEQ ID NO: 3 or SEQ ID NO: 7; or
(b) a variable light (VL) domain comprising the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 9; or
(c) both (a) and (b).
9. The isolated polynucleotide of claim 8 , wherein the antibody or biologically active fragment thereof comprises a VH domain comprising the amino acid sequence of SEQ ID NO: 3 and a VL domain comprising the amino acid sequence of SEQ ID NO: 5.
10. The isolated polynucleotide of claim 8 , wherein the antibody or biologically active fragment thereof comprises a VH domain comprising the amino acid sequence of SEQ ID NO: 7 and a VL domain comprising the amino acid sequence of SEQ ID NO: 9.
11. The isolated polynucleotide of claim 8 , wherein the biologically active fragment is an Fab fragment, Fab' fragment, an F(ab′) 2 fragment, a single chain Fv (scFv), or a disulfide-linked Fv (dsFv).
12. The isolated polynucleotide of claim 8 , wherein the antibody is an IgG.
13. A vector comprising the polynucleotide of claim 8 .
14. An isolated host cell comprising the vector of claim 13 .